Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 5/20 | 0.36 |
| ▸ | RAB9A | P51151 | 5/20 | 0.36 |
| ▸ | RARA | P10276 | 4/20 | 0.35 |
| ▸ | RARB | P10826 | 4/20 | 0.35 |
| ▸ | RARG | P13631 | 4/20 | 0.35 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.33 |
| ▸ | GRM5 | P41594 | 2/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | WNT3A | P56704 | 1/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8499337 | 0.89 | CTNNB1 (0.39) | NPC1RAB9ACYP3A4CTNNB1WNT3A | |
| SCHEMBL8659339 | 0.88 | NPC1 (0.36) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL8681448 | 0.85 | NPC1 (0.39) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL8681735 | 0.82 | NPC1 (0.35) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL9817651 | 0.81 | RARB (0.53) | RARARARBRARGCYP26A1CYP3A4 | |
| SCHEMBL8565252 | 0.80 | KMT2A (0.45) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL9817872 | 0.80 | ACACB (0.45) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL7566669 | 0.78 | RARA (0.35) | NPC1RAB9ARARARARBRARG | |
| SCHEMBL9817728 | 0.76 | TSHR (0.37) | RAB9ARARARARBRARGCYP3A4 | |
| SCHEMBL20636854 | 0.76 | RARA (0.37) | RARARARBRARGCYP26A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5053523-A | Chemical intermediate for compounds having retinoic acid-like activity | ALLERGAN, INC. (US) | 1991-10-01 | — | — | US | disclosed |